Abstract
Increased awareness and sensitivity of general physicians have increased the early diagnoses of seronegative arthritis in young patients, while new agents such as anti-TNF blockers have significantly changed the treatment of the disease. To investigate the prevalence, the clinical manifestations, and the ability for military service of young Greek males (18–30 years old) with ankylosing spondylitis (AS) in the pre-anti-TNF era. We retrospectively studied the AS cases recorded from 1989 to 1995 of the rheumatology department of the largest General Military Hospital in Greece; the diagnosis was based on the modified New York criteria for AS. A total of 285 AS cases were diagnosed among 357,184 young men. The overall prevalence of AS on December 1995 was estimated at 8.2 cases per 10,000 young men (95 % C.I. 7.2–9.2). All the patients had chronic back pain. Two hundred forty (84 %, 95 % C.I. 79–88 %) patients presented sacroiliitis of whom 163 (68 %, 95 % C.I. 62–73 %) were bilateral. Two hundred five patients (72 %, 95 % C.I. 66–77 %) had peripheral joint involvement. Thirty-one patients presented with anterior uveitis (11 %, 95 % C.I. 8–15 %). One patient had IgA nephropathy. None had gut involvement. HLA-B27 antigen was found in 257 patients (90 %, 95 % C.I. 86–93 %). Ninety-one patients (32 %, 95 % C.I. 27–38 %) had permanent discharge from the military service, while 128 (45 %, 95 % C.I. 39–51 %) were able for auxiliaries attendances. The prevalence of AS for the age group 18–30 years old in this young Greek men cohort was significantly lower than in other Caucasian European populations, and the clinical manifestations were considered as mild.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Feldtkeller E, Khan MA, van der Heijde D, van der Linden S, Braun J (2003) Age at disease onset and diagnosis delay in HLA-B27 negative vs positive patients with ankylosing spondylitis. Rheumatol Int 23(2):61–66
Khan MA, Kushner I, Braun WE (1977) Comparison of clinical features in HLA-B27 positive and negative patients with ankylosing spondylitis. Arthritis Rheum 20(4):909–912
Lau CS, Burgos-Vargas R, Louthrenoo W, Mok MY, Wordsworth P, Zeng QY (1998) Features of spondyloarthritis around the world. Rheum Dis Clin North Am 24(4):753–770
Braun J, Bollow M, Remlinger G, Eggens U, Rudwaleit M, Distler A, Sieper J (1998) Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum 41(1):58–67
Saraux A, Guedes C, Allain J, Devauchelle V, Valls I, Lamour A, Guillemin F, Youinou P, Le Goff P (1999) Prevalence of rheumatoid arthritis and spondyloarthropathy in Brittany, France. Societe de Rhumatologie de l'Ouest. J Rheumatol 26(12):2622–2627
Kidd BL, Cawley MI (1988) Delay in diagnosis of spondarthritis. Br J Rheumatol 27(3):230–232
van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27(4):361–368
Carter ET, McKenna CH, Brian DD, Kurland LT (1979) Epidemiology of ankylosing spondylitis in Rochester, Minnesota, 1935–1973. Arthritis Rheum 22(4):365–370
Trontzas P, Andrianakos A, Miyakis S, Pantelidou K, Vafiadou E, Garantziotou V, Voudouris C (2005) Seronegative spondyloarthropathies in Greece: a population-based study of prevalence, clinical pattern, and management. The ESORDIG study. Clin Rheumatol 24(6):583–589
Doran MF, Brophy S, MacKay K, Taylor G, Calin A (2003) Predictors of longterm outcome in ankylosing spondylitis. J Rheumatol 30(2):316–320
Brown MA, Jepson A, Young A, Whittle HC, Greenwood BM, Wordsworth BP (1997) Ankylosing spondylitis in West Africans—evidence for a non-HLA-B27 protective effect. Ann Rheum Dis 56(1):68–70
Gran JT, Husby G (1993) The epidemiology of ankylosing spondylitis. Semin Arthritis Rheum 22(5):319–334
Khan MA (2000) Update: the twenty subtypes of HLA-B27. Curr Opin Rheumatol 12(4):235–238
Khan MA (2002) Update on spondyloarthropathies. Ann Intern Med 136(12):896–907
Pachoula-Papasteriadis C, Ollier W, Cutbush S, Economidou J, Festenstein H (1989) HLA antigen and haplotype frequencies in Greeks. Tissue Antigens 33(4):488–490
Rudwaleit M, Haibel H, Baraliakos X, Listing J, Ma¨rker-Hermann E, Zeidler H, Braun J, Sieper J (2009) The early disease stage in axial spondylarthritis. results from the German spondyloarthritis inception cohort. Arthritis Rheum 60:717–727
Brophy S, Pavy S, Lewis P, Taylor G, Bradbury L, Robertson D et al (2001) Inflammatory eye, skin, and bowel disease in spondyloarthritis genetic, phenotypic, and environmental factors. J Rheumatol 28:2667–73
Gran JT, Hordvik M, Husby G (1984) Roentgenological features of ankylosing spondylitis. A comparison between patients attending hospital and cases selected through an epidemiological survey. Clin Rheumatol 3:467–72
Wynn Parry CB (1966) Management of ankylosing spondylitis. Proc R Soc Med 59:619–623
Alamanos Y, Papadopoulos NG, Voulgari PV, Karakatsanis A, Siozos C, Drosos AA (2004) Epidemiology of ankylosing spondylitis in Northwest Greece, 1983–2002. Rheumatology (Oxford) 43(5):615–618
Acknowledgments
We would like to thank the medical and nursing staff of the rheumatology unit of 401 General Military Hospital of Athens for looking after the AS patients during the study period (1989–1995).
Disclosures
None
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kassimos, D.G., Vassilakos, J., Magiorkinis, G. et al. Prevalence and clinical manifestations of ankylosing spondylitis in young Greek males. Clin Rheumatol 33, 1303–1306 (2014). https://doi.org/10.1007/s10067-014-2574-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-014-2574-6